Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions

scientific article published on 13 March 2008

Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2125.2008.03144.X
P932PMC publication ID2485232
P698PubMed publication ID18341680
P5875ResearchGate publication ID5510028

P2093author name stringChristine A Haller
Peyton Jacob
Neal Benowitz
Minjing Duan
P2860cites workPsychophysical bases of perceived exertionQ29615667
Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloidsQ33928222
Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysisQ34188002
Hemodynamic effects of ephedra-free weight-loss supplements in humansQ34451168
Coffee consumption and risk of type 2 diabetes: a systematic reviewQ36184343
Coffee, diabetes, and weight controlQ36615589
Influence of exercise on the pharmacokinetics of drugsQ37944766
Effect of caffeine and ephedrine ingestion on anaerobic exercise performanceQ43688835
An acute oral dose of caffeine does not alter glucose kinetics during prolonged dynamic exercise in trained endurance athletesQ43739713
Effect of ingesting caffeine and ephedrine on 10-km run performanceQ43877137
Effects of exercise and thermal stress on caffeine pharmacokinetics in men and eumenorrheic womenQ44138662
Short-term metabolic and hemodynamic effects of ephedra and guarana combinationsQ46375058
Comparison of caffeine and theophylline ingestion: exercise metabolism and endurance.Q54134183
Performance and metabolic responses to a high caffeine dose during prolonged exerciseQ55044504
What is the dose-response relationship between exercise training and blood pressure?Q56955080
Effects of caffeine, fructose, and glucose ingestion on muscle glycogen utilization during exerciseQ68543423
Effects of physical activity and immobilization on plasma digoxin concentration and renal digoxin clearanceQ71823225
From the Centers for Disease Control and Prevention. Adverse events associated with ephedrine-containing products--Texas, December 1993-September 1995Q71826026
Effects of caffeine on muscle glycogen utilization and the neuroendocrine axis during exerciseQ73892759
Gastrointestinal function during exercise: comparison of water, sports drink, and sports drink with caffeineQ74218061
Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exerciseQ74485761
Gastric emptying as a regulatory factor in fluid uptakeQ77051557
Effect of caffeine on metabolism, exercise endurance, and catecholamine responses after withdrawalQ77369311
Caffeine, performance, and metabolism during repeated Wingate exercise testsQ77369315
Combined caffeine and ephedrine ingestion improves run times of Canadian Forces Warrior TestQ77386186
Thermal regulation in the heat during exercise after caffeine and ephedrine ingestionQ77894434
The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in menQ83154471
Metabolic and exercise endurance effects of coffee and caffeine ingestionQ93911870
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectpharmacologyQ128406
P304page(s)833-840
P577publication date2008-03-13
P1433published inBritish Journal of Clinical PharmacologyQ176044
P1476titleHuman pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions
P478volume65

Reverse relations

cites work (P2860)
Q42373405(R,R)-Disynephrine ether bis-(hydrogen sulfate).
Q37831732A review of psychophysiological stressors on pharmacokinetics.
Q24599282A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine
Q26825630A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects
Q47908750Acute consumption of p-synephrine does not enhance performance in sprint athletes.
Q42282816Acute p-synephrine ingestion increases fat oxidation rate during exercise
Q38163000An evidence-based systematic review of bitter orange (Citrus aurantium) by the Natural Standard Research Collaboration
Q46584274Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial
Q45414530Cardiovascular toxicity of Citrus aurantium in exercised rats
Q38984887Combined Effects of Phytochemicals and Exercise on Fatty Acid Oxidation
Q48051885Dose-Response Effects of p-Synephrine on Fat Oxidation Rate During Exercise of Increasing Intensity
Q34648247Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans
Q34893795Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes
Q34477293Efficacy and Safety of White Willow Bark (Salix alba) Extracts
Q83450530Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium
Q55554417Lack of Evidence that p-Synephrine is Responsible for STEMI.
Q86006902Multiple dosing of ephedra-free dietary supplements: hemodynamic, electrocardiographic, and bacterial contamination effects
Q38921732Phytochemical compounds in sport nutrition: Synephrine and hydroxycitric acid (HCA) as examples for evaluation of possible health risks
Q46262928Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study
Q38655858Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine
Q47156955Scientific Opinion on the safety of caffeine
Q39532815The Effects of Supplementation with p-Synephrine Alone and in Combination with Caffeine on Metabolic, Lipolytic, and Cardiovascular Responses during Resistance Exercise
Q57570291The action of p-synephrine on hepatic carbohydrate metabolism and respiration occurs via both Ca2+-mobilization and cAMP production
Q47683541The effect of operational stressors on ibuprofen pharmacokinetics
Q36069351The effects of supplementation with P-Synephrine alone and in combination with caffeine on resistance exercise performance
Q90448229The influence of citrus aurantium and caffeine complex versus placebo on the cardiac autonomic response: a double blind crossover design
Q37863654The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine
Q47322199Toxicological effects of a mixture used in weight loss products: p-synephrine associated with ephedrine, salicin, and caffeine.
Q52842935[Risk assessment of synephrine in dietary supplements].
Q89891932p-Synephrine, ephedrine, p-octopamine and m-synephrine: Comparative mechanistic, physiological and pharmacological properties

Search more.